| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +26,050 | 100% | $1.92 | +$50,016 |
| Sells | 0 | ||||
| Net | +1 | +26,050 | 100% | +$50,016 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Faheem Hasnain | President & CEO, Director | $22,610,034 | 02 Jan 2026 | ||
| Christian Waage | EVP, Tech Ops and Admin | $3,193,472 | 02 Jan 2026 | ||
| Bryan Giraudo | Coo/Cfo | $3,148,483 | 02 Jan 2026 | ||
| Richard Aranda | Chief Medical Officer | $1,685,634 | 02 Jan 2026 | ||
| Robert Paul Smith Jr. | Chief Commercial Officer | $1,034,950 | 02 Jan 2026 | ||
| Caryn Peterson | EVP, Regulatory Affairs | $938,785 | 02 Jan 2026 | ||
| Sandra Milligan | Director | $111,456 | +$50,016 | +81% | 19 Aug 2025 |
| Laura Carter | Chief Scientific Officer | $60,088 | 20 Mar 2023 | ||
| Steven D. Nathan | Director | 25 Jun 2025 | |||
| John D. Quisel | Director | 25 Jun 2025 | |||
| Daniel Thomas O | Director | 25 Jun 2025 | |||
| Kristina M. Burow. | Director | 08 Jun 2023 | |||
| Russell J. Cox | Director | 25 Jun 2025 | |||
| Joshua H. Bilenker | Director | 09 Jun 2022 | |||
| Renee D. Gala | Director | 08 Jun 2023 | |||
| Skye Drynan | Director | 25 Jun 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Faheem Hasnain | GOSS | Common Stock | Award | 50.2% | 280,000 | 837,793 | 02 Jan 2026 | Direct | ||
| Faheem Hasnain | GOSS | Stock Option (Right to Buy) | Award | 1,680,000 | 1,680,000 | 02 Jan 2026 | Direct | |||
| Bryan Giraudo | GOSS | Common Stock | Award | 42.2% | 115,750 | 389,737 | 02 Jan 2026 | Direct | ||
| Bryan Giraudo | GOSS | Stock Option (Right to Buy) | Award | 693,750 | 693,750 | 02 Jan 2026 | Direct | |||
| Robert Paul Smith Jr. | GOSS | Common Stock | Award | 56.1% | 93,750 | 260,898 | 02 Jan 2026 | Direct | ||
| Robert Paul Smith Jr. | GOSS | Stock Option (Right to Buy) | Award | 562,500 | 562,500 | 02 Jan 2026 | Direct | |||
| Richard Aranda | GOSS | Common Stock | Award | 25.4% | 93,750 | 463,106 | 02 Jan 2026 | Direct | ||
| Richard Aranda | GOSS | Stock Option (Right to Buy) | Award | 562,500 | 562,500 | 02 Jan 2026 | Direct | |||
| Caryn Peterson | GOSS | Common Stock | Award | 48.3% | 84,500 | 259,333 | 02 Jan 2026 | Direct | ||
| Caryn Peterson | GOSS | Stock Option (Right to Buy) | Award | 506,250 | 506,250 | 02 Jan 2026 | Direct | |||
| Waage Christian | GOSS | Common Stock | Award | 11.6% | 84,500 | 814,061 | 02 Jan 2026 | Direct | ||
| Waage Christian | GOSS | Stock Option (Right to Buy) | Award | 506,250 | 506,250 | 02 Jan 2026 | Direct | |||
| Robert Paul Smith Jr. | GOSS | Common Stock | Award | 162,500 | 162,500 | 01 Oct 2025 | Direct | |||
| Waage Christian | GOSS | Common Stock | Award | 21.3% | 125,000 | 710,934 | 01 Oct 2025 | Direct | ||
| Bryan Giraudo | GOSS | Common Stock | Award | 195.4% | 181,250 | 273,987 | 01 Oct 2025 | Direct | ||
| Richard Aranda | GOSS | Common Stock | Award | 78.6% | 162,500 | 369,356 | 01 Oct 2025 | Direct | ||
| Faheem Hasnain | GOSS | Common Stock | Award | 363.7% | 437,500 | 557,793 | 01 Oct 2025 | Direct | ||
| Caryn Peterson | GOSS | Common Stock | Award | 250.8% | 125,000 | 174,833 | 01 Oct 2025 | Direct | ||
| Sandra Milligan | GOSS | Common Stock | Purchase | 81.4% | $50,016 | $1.92 | 26,050 | 58,050 | 19 Aug 2025 | Direct |
| Daniel Thomas O | GOSS | Stock Option (Right to Buy) | Award | 115,000 | 115,000 | 25 Jun 2025 | Direct | |||
| Steven D. Nathan | GOSS | Stock Option (Right to Buy) | Award | 115,000 | 115,000 | 25 Jun 2025 | Direct | |||
| Russell J. Cox | GOSS | Stock Option (Right to Buy) | Award | 115,000 | 115,000 | 25 Jun 2025 | Direct | |||
| John D. Quisel | GOSS | Stock Option (Right to Buy) | Award | 115,000 | 115,000 | 25 Jun 2025 | Direct | |||
| Sandra Milligan | GOSS | Stock Option (Right to Buy) | Award | 115,000 | 115,000 | 25 Jun 2025 | Direct | |||
| Skye Drynan | GOSS | Stock Option (Right to Buy) | Award | 115,000 | 115,000 | 25 Jun 2025 | Direct |